Faisal G. Sukhtian's Insider Trades & SAST Disclosures
Faisal G. Sukhtian's most recent trade in Outlook Therapeutics Inc was a trade of 12,323 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Faisal G. Sukhtian.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 12,323 | 12,323 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 134,430 | 134,430 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 56,636 | 56,636 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 19,771 | 19,771 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 94,441 | 94,441 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 07 Oct 2022 | 30,000 | 68,000 (0%) | 0% | 1.3 | 38,700 | Common Stock |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 74,878 | 74,878 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 21 Apr 2022 | 27,982,529 | 55,816,786 (105%) | 52% | - | Common Stock | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 21,878 | 21,878 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 02 Dec 2021 | 18,000 | 38,000 (0%) | 0% | 1.4 | 25,200 | Common Stock |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 44,753 | 44,753 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Purchase of securities on an exchange or from another person at price $ 1.82 per share. | 19 Apr 2021 | 10,000 | 20,000 (0%) | 0% | 1.8 | 18,200 | Common Stock |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 20,873 | 20,873 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 17 Sep 2020 | 10,000 | 10,000 (0%) | 0% | 0.7 | 6,731 | Common Stock |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2020 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges